Table 5.
Non-biological technologies for the treatment of antiviral drugs.
| Antiviral Drugs | Matrix | Concentration | Treatment Technology | Process Conditions | Removal or Q(mg/g) | References |
|---|---|---|---|---|---|---|
| Acyclovir | Distilled water | 400 mg/L | Adsorption | Temperature: 39 °C, pH:8: powdered adsorbent activated carbon, adsorbent dose: 2 g/L | 90.3 % | [66] |
| Sofosbuvir | Distilled water | 0.1 mM | Adsorption | pH: 6.8, adsorbent: e- perlite adsorbent dose: 20 g/L |
58.5 % | [67] |
| Didanosine, Nevirapine, Ritonavir, Efavirenz, Stavudine | Wastewater treatment plant influent and effluent Distilled water |
0.5–1.25 mg/L | Adsorption | Contact time:15 min to 120 min, temperature: 15 to 60 °C,pH: 3 to 12 | 64.9 mg/g-200.5 mg/g | [60] |
| Acyclovir | Distilled water | 100 mg/L | Adsorption | Temperature: 45 °C, pH:11, adsorbent: powdered activated charcoal, adsorbent dose: 4 g/L, equilibrium contact time: 75 min. | 98 % | [141] |
| Zidovudine (ZDV) Lamivudine (3TC) Nevirapine (NVP) |
Wastewater treatment plant effluent | 20 μM | Photolysis (UV) | pH:7.7–8.1, electrical energy dose: 6.67 kWh/103 L H2O2 dose:20.4 mg/L, Cl2 dose:42.6 mg/L | ZDV: >90 % 3TC:~50 % NVP:<20 % |
[50] |
| UV/H2O2 | ZDV: >90 % 3TC:~75 % NVP:>55 % |
|||||
| UV/Cl2 | ZDV:~90 % 3TC:~80 % NVP:~20 % |
|||||
| Acyclovir | Open-water treatment wetland |
302 ± 58 ng/L | Photolysis (solar energy) |
Depth: 25–30 cm, pH: 7.7–9.0 NO3−:3.5–7.5 mg/L, DOC: 3.7–5.6 mg/L C, DIC:45–54 mg/L C |
70 % | [142] |
| Acyclovir (ACV) Lamivudine (LMVD) |
RO brine A and B from municipal wastewater reuse facilities | 5 μM | UV/H2O2 | Incident UV fluence: 1000 mJ/cm2 H2O2: 5 mM, K2S2O8: 5 mM |
ACV: ~35 % (RO Brine A) ACV: ~45 % (RO Brine B) LMVD: ~80 % (RO Brine A) LMVD:~95 % (RO Brine B) |
[72] |
| UV/S2O82− | ACV: ~30 % (RO Brine A) ACV:~45 % (RO Brine B) LMVD: 100 % (RO Brine A) LMVD:~100 % (RO Brine B) |
|||||
| Oseltamivir acid (the active metabolite of Tamiflu®) | Secondary effluent in pilot-scale WWTP | 1 μM | Ozonation (O3) | >0.3 g O3 g−1 DOC 0.5 g O3 g−1 DOC |
>50 % < detection limit |
[77] |
| Tamiflu (oseltamivir phosphate) | Ultrapure water | 21 μM | Photocatalysis | P25 (one of the powdered TiO2) concentration: 20 and 100 mg/ L UV-A irradiation time: 80 min pH: 5.8 ± 0.1 |
>95 % | [64] |
| Abacavir | Deionized water | – | Electrochemical Degradation | Anode:Ti/SnO2-Sb Time: in 10 min Current density: 0.2 mA/cm2 |
>97 % | [78] |
| Lamivudine | Deionized water | 2.5 mg/L | Electrochemical Degradation | Current density: 10 mA/cm2 | 98.3 % | [79] |
| Initial pH:6.7 |